In the past decade, a large number of genetic biomarkers have been discovered through large-scale genome wide association studies (GWASs) in Alzheimer's disease (AD), such as APOE, TOMM40 and CLU. Despite this significant progress, existing genetic findings are largely passengers not directly involved in the driver events, which presents challenges for replication and translation into targetable mechanisms. In this paper, leveraging the protein interaction network, we proposed a modularity-constrained Lasso model to jointly analyze the genotype, gene expression and protein expression data. With a prior network capturing the functional relationship between SNPs, genes and proteins, the newly introduced penalty term maximizes the global modularity of the subnetwork involving selected markers and encourages the selection of multi-omic markers with dense functional connectivity, instead of individual markers. We applied this new model to the real data in ROS/MAP cohort for discovery of biomarkers related to cognitive performance. A functionally connected subnetwork involving 276 multi-omic biomarkers, including SNPs, genes and proteins, were identified to bear predictive power. Within this subnetwork, multiple trans-omic paths from SNPs to genes and then proteins were observed, suggesting that cognitive performance can be potentially affected by the genetic mutations due to their cascade effect on the expression of downstream genes and proteins.
pathogenesis remain a challenge. Identification of novel biomarkers or functionally 10 validating existing biomarkers becomes increasingly important for discovery of new 11 potential future therapeutic targets. 12 Recently, there is a substantial increase in AD multi-omic data. Example projects 13 include the Alzheimer's Disease Neuroimaging Initiative (ADNI) [2] and the Religious 14 Orders Study and Memory and Aging Project (ROSMAP) [3] . Instead of limiting 15 their perspective to a single -omics layer, these data collections create a molecular 16 landscape spanning the genome, transcriptome, proteome and metabolome. Coupling 17 with systems biology networks (e.g., protein-protein interaction (PPI) network), these 18 data provides a valuable resource with rich content and opens numerous opportunities 19 for more comprehensive analyses of AD. These multi-omics data has been increasingly 20 recognized to be a potential key enabler of novel biomarker discovery [4, 5] . It not only 21 allows us to examine the disease from different -omics layers, but also provides insights 22 into their interactions which is critical for translation of genetic findings into targetable 23 mechanism. 24 Despite this great potential, the power of multi-omic data has not been fully unleashed. 25 Much research effort of existing studies has been on single type of -omics data without 26 acknowledging the interconnections between -omics layers. This shortcoming is largely 27 due to the limited availability of computational methods that are sufficiently powerful 28 and comprehensive enough to handle the high dimensionality and heterogeneity of multi-29 mic data. In addition, major findings generated from current -omics studies have been 30 largely restricted to relatively simple patterns. They are mostly individual biomarkers, 31 possibly without functional interactions, which presents difficulties to validate these 32 findings and to relate them to downstream biology [6, 7] . To address this problem, some 33 recent studies propose to seek common genetic markers with evidence from more than 34 one -omics layer [8] [9] [10] , which are expected to more reliable for further experimental 35 validation. However, this simple overlap strategy may be too stringent as -omic features 36 in different layers are not completely mapped in a one-to-one relationship. 37 In this paper, leveraging the functional interaction network in REACTOME, we pro-38 pose a modularity-constrained Lasso model to jointly analyze genotype, gene expression 39 and protein expression data. We aim to identify a set of SNPs, genes and proteins as 40 biomarkers, forming a subnetwork with functional connections cutting across different 41 -omics layers. Compared to individual mutations, genes or proteins identified using 42 traditional methods, such connected pattern can help improve not only the reliability of 43 identified biomarkers, but also their replicability and interpretability. 44 
Method

45
Study cohort 46 All the data analyzed in the present report were obtained from the Religious Orders Study 47 (ROS) and Memory and Aging Project (MAP). It was launched by Rush University 48 to build a cohort from religious communities to measure the progression of amnestic 49 mild cognitive impairment (MCI, a prodromal stage of AD) and early probable AD. 50 The combined ROS/MAP cohort includes around 600 participants under age 90, which 51 constitute a very rich repository of multi-modal data including GWAS data, whole 52 genome sequencing (WGS) data, cognitive, behavioral and clinical data. The more 53 detailed description could be found in [3] . In this paper, GWAS genotype data and 54 quality controlled RNA-Seq gene expression and protein expression data collected from 55 prefrontal cortex tissue in the brain were downloaded. To perform the proposed joint 56 analysis, only subjects with all three types of -omics data were included. In total, we 57 have 262 subjects (115 healthy controls (HC), 67 mild cognitive impairment (MCI), 80 58 AD patients) with full set of genotype, RNA-seq gene expression and proteomic data. 59 The detailed demographic information can be found in Table 1 . ROS/MAP samples were genotypes on the Affymetrix GeneChip 6.0 platform [11] . 62 We performed sample and SNP quality control procedures on GWAS data (SNP call 63 rate<95%, Hardy-Weinberg equilibrium test p<10 −6 in controls, and frequency filtering 64 (MAF<1%) were performed. After performing the standard quality control procedures 65 for genetic markers and subjects , only non-Hispanic Caucasian participants were selected 66 by clustering with CEU (Utah residents with Northern and Western European ancestry 67 from the CEPH collection) + TSI (Toscani in Italia) populations using HapMap 3 68 genotype data and the multidimensional scaling (MDS) analysis [12] . Un-genotyped 69 SNPs were imputed using MaCH and the 1000 Genomes Project as a reference panel [13] . 70
RNA-Seq gene expression preparation
71
RNA-Seq gene expression data in the ROS/MAP cohort were collected from the prefrontal 72 cortex tissue in the brain. The RNA-Seq data were recently reprocessed in parallel with 73 other AMP-AD RNAseq datasets, and this second version of the data were downloaded for 74 our subsequent analysis. The input data for the RNAseq reprocessing effort was aligned 75 reads in bam files that were converted to fastq using the Picard SamToFastq function. 76 Fastq files were re-aligned to the reference genome using STAR with twopassMode set 77 as Basic. Gene counts were computed for each sample by STAR by setting quantMode 78 as GeneCounts. These gene level counts further went through normalized and adjusted 79 to remove the effects of relevant factors such as age, gender, education, batch, RNA 80 integrity number (RIN) and post moterm interval (PMI). Detailed reprocessing and 81 normalization steps can be found in the AMP-AD knowledge portal (https://www. 82 synapse.org/#!Synapse:syn9702085/).
83
Protein expression data preparation 84 SRM proteomics was performed using frozen tissue from dorsolateral prefrontal cortex 85 (DLPFC). The samples were prepared for LC-SRM analysis using standard protocol 86 as described in [14, 15] . All the data were manually inspected to ensure correct peak 87 assignment and peak boundaries.The abundance of endogenous peptides was quanti-88 fied as a ratio to spiked-in synthetic peptides containing stable heavy isotopes. The 89 "light/heavy" ratios were log2 transformed and shifted such that median log2-ratio is 90 zero. Normalization adjusted for differences in protein amounts between the samples. 91 During that normalization, we shifted the log2-ratios for each sample to make sure 92 the median is set at zero. Detailed processing steps can be found in the AMP-AD 93 knowledge portal (https://www.synapse.org/#!Synapse:syn8456629). Using the re-94 gression weights derived from the healthy control participants, peptide abundance data 95 were further adjusted to remove the effects of the age at death, gender, education, PMI 96 and batch.
97
Selection of SNPs, genes and proteins 98 We focused our analysis on a set of SNPs, genes and proteins with known functional 99 connections. Though we have genome-wide genotype and transcriptome-wide gene 100 expression data available in the ROS/MAP cohort, only a limited number of proteins 101 are measured and form a bottleneck for the joint -omics data analysis. To address 102 this problem, we used these proteins as seeds to select a subset of SNPs and genes for 103 subsequent analysis. As shown in Fig 1, in the proteomic level, abundance level of 104 186 peptides, from 126 unique genes, were measured in the ROS/MAP project. When 105 mapped to the functional interaction network in REACTOME [16] , where all protein 106 interactions were manually curated from pathways with directionality information, these 107 genes are found to interact with 954 genes. After excluding those without gene ID, totally 108 743 genes with RNA-seq data were included in the transcriptomic level. In the genomic 109 level, SNPs located on the upstream of these genes (boundary: 5K) were extracted. 110 To ensure the functional connection of selected SNPs and their downstream genes, 111 we included only SNPs significantly affecting the transcrition factor binding activity, 112 as shown in SNP2TFBS database [17] . This relationship between SNPs, genes and 113 proteins/peptides are used as the trans-omic network to guide the search of functionally 114 connected biomarkers in the subsequent analysis.
115
Memory outcomes 116
In the ROS/MAP project, cognitive performance of participants was estimated through 117 the mini mental state examination, a standardized screening measure for collecting 30 118 items in related with dementia [18, 19] . This score ranges from 0 to 30, and is scaled 119 to quantify the severity of dementia. In this study, we use this memory test score as 120 the AD quantitative trait for discovery of functionally connected biomarkers. Using the 121 regression weights derived from the healthy control participants, the memory score is 122 adjusted to remove the effect of sex, education and age.
123
Modularity-constrained Lasso
124
Throughout this section, we write matrices as boldface uppercase letters and vectors as 125 boldface lowercase letters. Given a matrix M = (m ij ), its i-th row and j-th column are 126 denoted as m i and m j respectively. Let X = [x 1 , x 2 , ..., x n ] T be the multi-omic features 127 as predictors and y = [y 1 , y 2 , ..., y n ] T be the disease quantitative trait as outcome (i.e., 128 cognitive performance). Here, x j ⊆ R p is a concatenated vector of genotype, gene 129 expression and protein expression data for j-th subject.
130
The least absolute shrinkage and selection operator (Lasso) is a shrinkage and selection 131 method for linear regression [20] . It minimizes the usual sum of squared errors with a 132 bound on the sum of the absolute values of the coefficients, which is also known as L1 133 norm (Eq. 1).
With this constraint, Lasso aims to minimize the number of selected features, which 135 significantly improved the interpretability of results compared to traditional linear 136 regression, where almost all features are considered to be outcome-relevant with non-137 zero weight. However, when dealing with a group of highly correlated features, L1 138 norm penalty will result in a random selection. In this case, multiple runs of Lasso 139 on the same set of data will possibly generate different set of selected features, which 140 presents challenges for replicating and interpreting the results. To address this problem, 141 several groups proposed to explicitly incorporate the correlation structure into the 142 sparse prediction model and encourage the selection/exclusion of all highly correlated 143 features [21] [22] [23] [24] . Among those is GraphNet, where a graph G ⊆ R p×p indicating the 144 correlation structure between predictors is used as a priori to guide the feature selection 145 (Eq. 2) [24] . Here, L is the corresponding Laplacian matrix of graph G. However, 146 GraphNet only takes account into local topology information with a focus on pairwise 147 similarity. For multi-omic biomarker discovery, using this penalty can not guarantee the 148 selected features are densely connected in the prior network.
In this paper, we propose a new modularity-constrained Lasso which leverages the 150 global network property to encourage the selection of a sub-network module rather 151 than individual markers scattered in the prior network. Given the trans-omic network 152 capturing the functional interaction between SNPs, genes and proteins, we formulate 153 it as a graph and its corresponding adjacency matrix is denoted as
. It evaluates whether the number 155 of links is significantly more than expected. h i and h j are the degrees of the i-th and 156 j-th node in the network, and m is the total number of links in the network. To impose 157 a modular structure in the identified biomarkers, we propose a new penalty term as 158 P M (w, B) =< w T w, B >, inspired by the module identification problem [26, 27] . Here, 159 <> is the Frobenius inner product defined by < A, B >= tr(A T B). Maximizing the 160 Frobenius inner product between w T w and the modularity matrix B encourages the 161 selection of features with dense functional connections in the prior multi-omic network. 162
Taken together, our new modularity-constrained Lasso objective is formulated as in Eq. 163 3.
Here, λ and t are the parameters that control and balance the contribution from two 165 regularization terms. Note that the objective function in Eq. 3 is not convex because 166 the modularity matrix B used in P M (w, B) =< w T w, B > is indefinite. To make B 167 negative-definite, we introduced an auxiliary function where B is replaced by B − λ B I 168 and λ B is the absolute maximum eigenvalue of B. Eq. 3 can be easily solved by obtaining 169 a closed form solution without L1 constraint, followed by soft-threshold method [20] .
170
Results
171
Performance comparison between M-Lasso and G-Lasso
172
In this section, we denote our modularity-constrained Lasso as M-Lasso and GraphNet-173 constrained Lasso as G-Lasso. For both methods, nested 5-fold cross validation (CV) 174 procedure was applied to tune the parameters based on root mean squared error (RMSE) 175 and the portion of different diagnosis groups was kept the same in different folds. As can 176 be observed, the major difference between Eq. 2 and Eq. 3 is the penalty term and they 177 have the same set of parameters. The parameters are tuned with the range set from 178 [10 −6 10 −5 10 −4 10 −3 10 −2 10 −1 10 0 10 1 10 2 ]. For fair comparison, both methods were 179 evaluated using the same partition of subjects during the cross validation procedure.
180
Shown in Table 2 is the root mean square error estimated by M-Lasso and G-Lasso 181 on test data set across five folds. As we can observe, M-Lasso consistently outperforms 182 G-Lasso with smaller prediction error over all 5 folds. For feature selection, M-Lasso identified around 600 -omics features, including SNPs, 184 genes and proteins, to be predictive of cognitive performance, while G-Lasso only 185 identified a handful of them (i.e., less than 20 for all 5 folds). When mapped to the 186 prior functional connectivity network, markers identified by G-Lasso scatters across 187 the network with few connections, which suggests that the local topology information 188 used in GraphNet penalty is not strong enough to form subnetwork structure among 189 identified biomarkers. For M-Lasso, -omics biomarkers identified are largely connected 190 to each other in the prior network. Take the result from one fold as example, 650 -omics 191 features were selected, including 255 SNPs, 339 genes and 56 proteins. The largest 192 connected network component involves 276 -omics features with 366 edges (Fig. 2) . 193 The rest of the multi-omic markers identified in M-Lasso mostly form small connected 194 components, ranging in size from 2 to 50. These features are found predictive yet not 195 well functionally connected, possibly due to the fact that they are false positives or their 196 functional connections have not been previously studied yet. In the subsequent part, we 197 focus on the multi-omic biomarkers in the largest connected component, which are both 198 predictive of cognitive performance and functionally connected with evidence from prior 199 knowledge.
Functionally connected multi-omic biomarkers 201 Shown in Fig. 2 are the top 7 connected components obtained after mapping 650 -omics 202 features back to the prior network. Size of each node is made proportional to their degree. 203 It can be easily observed that there are multiple trans-omic paths from SNPs to genes 204 and then proteins. Note that these SNPs are located upstream of their connected genes 205 and has significant effect on the transcription factor binding activity. Thus, these SNPs 206 are very likely to have an influence on the expression of their connected genes. Also, 207 the functional interaction between genes and proteins are curated from REACTOME 208 pathways with direction information. Therefore, genes have a regulatory role toward 209 the expression of their connected proteins in the prior network. Taken together, these 210 trans-omic paths suggest that cognitive performance can be potentially affected by the 211 genetic mutations (i.e., SNPs) due to their cascade effect on the expression of downstream 212 genes, which further regulate the protein expression. We further examined all 28 SNPs 213 involved in the largest connected component in BRAINEAC database. 25 of them were 214 found to be expression quantitative locus (eQTLs) in the prefrontal cortex tissue, which 215 gives further support to our discovery of trans-omic paths as biomarkers.
216
For the largest connected components, we further performed network analysis using 217 NetworkAnalyzer in Cytoscape [28] and identified the -omic biomarkers with top centrality 218 values, such as degree, betweenness and closeness (Table 3) . Top nodes by degree in 219 this subnetwork included proteins PIK3R1, FYN, CD44 and RPS2, and genes GRB2, 220 FBXO2, EP300, SV2A and SPCS3. Most hub nodes are also found to have the top 221 centrality value in betweenness, closeness and clustering coefficient, such as PIK3R1, 222 FYN, and EP300. Majority of these genes and proteins have been previously reported 223 in association with AD. For example, PIK3R1 encodes the regulatory subunit of the 224 phosphoinositide-3-kinase protein complex PI3Ks, which are known to play a key role in 225 insulin signaling. Results from recent studies start to show evidence of intrinsic insulin 226 resistance inside AD brains [29] . The hub gene EP300 encodes the enzyme histone 227 acetyltransferase p300 or E1A-associated protein p300, also known as EP300 or P300. 228 This enzyme functions as histone acetyltransferase that regulates transcription of genes 229 via chromatin remodeling. Findings from multiple studies have suggested the potential of 230 P300 to act as a biomarker for dementia assessment and monitoring AD. Meta-analysis 231 of P300 amplitude and latency reveals useful information about the early stages of 232 AD [30, 31] . In addition, both GRB2 and FBXO2 were found to interact with APP, a 233 well-known gene related to AD. GRB2 interacts with APP requiring phosphorylation 234 of APP at Tyr-682 [32] . This could lead to the activation of the MAPK pathway, 235 since GRB2 are known to link growth factor receptors to signaling pathways, such as 236 MAPK and PI3K, and participate in oncogenic proliferation, neuronal development, 237 cell differentiation, and apoptosis [33] [34] [35] [36] [37] [38] The hub gene FBXO2 participates in APP 238 processing by promoting degradation of APP cleaving β-secretase [39] .
239
Pathway enrichment analysis 240
For 168 genes and 37 proteins in the largest connected subnetwork, we performed 241 pathway enrichment analysis using ClueGO based on the Kyoto Encyclopedia of Genes 242 and Genomes (KEGG) database [40, 41] . In total, 74 pathways were found to be 243 significantly enriched by our gene/protein set, with Bonferroni corrected term p-value 244 smaller than 5% (P≤0.05). Shown in Table 4 was the top 20 enriched KEGG pathways 245 with smallest p values after correction. The top hit is PI3K -Akt signaling pathway, 246 a major mediator of effects of insulin. Two recent studies have found a significant 247 correlation between peripheral insulin resistance and brain Aβ levels as measured by 248 Pittsburgh compound B-positron emission tomography (PiB-PET) [42, 43] . The impaired 249 insulin-PI3K-Akt signaling observed in the AD brain has led to clinical trials studying 250 whether the enhancement of this pathway using intranasal insulin (IN) treatment is 251 beneficial [44] . Other enriched pathways that are previously reported with a key role in 252 AD include Focal adhesion [45] , Ras signaling pathway [46] , ECM-receptor interaction [47] , 253 MAPK signaling pathway [48] , Rap1 signaling pathway [49] , etc. In addition, we observe 254 many of the top enriched pathways are related to cancer, such as PI3K -Akt signaling 255 pathway, Prostate cancer and small lung cancer. This finding provide support to the 256 hypothesis of shared pathological mechanism between cancer and AD [50] [51] [52] [53] .
257 Table 4 . Top enriched KEGG pathways by the gene and protein markers in the largest subnetwork. In this study, we proposed a new modularity-constrained Lasso model to jointly ana-259 lyze the genotype, RNA-Seq gene expression and protein expression data. The newly 260 introduced penalty term maximizes the global modularity of selected biomarkers in the 261 prior network and encourages the selection of multi-omic biomarkers forming network 262 modules. Compared to the GraphNet penalty that enforces local pairwise similarity, 263 modularity-based penalty helps identify more biomarkers with significantly improved 264 functional connectivity. In particular, we found that some biomarkers form trans-omic 265 paths from SNP to gene and then protein, suggesting the potential cascade effect of 266 genotype on the downstream transcriptome and proteome level. To the best of our 267 knowledge, this is the first study that explored the potential of functional multi-omic 268 subnetworks as biomarkers in AD.
Pathway
Number of markers in the pathway
269
Despite the promising findings, this study has multiple limitations. First, only one 270 disease quantitative trait is used as outcome in the prediction model. Considering 271 the potential bias introduced from data collection procedure, the biomarkers and their 272 functional connectivity network identified here may not reflect the optimal pattern. 273 Incorporating multiple correlated outcomes and performing a multitask prediction will 274 possibly help improve the performance. Second, our proposed model is not capable of 275 handling the missing data problem. Each subject has to have all the -omics data to be 276 included in the analysis. Therefore, many subjects with missing data in one or more 277 -omics layers are inevitably excluded and only a small portion of the big -omics data is 278 utilized. Future efforts are warranted to further improve this model. 
